General Nuclear Medicine Track

The general nuclear medicine track features a wide-ranging scope of sessions developed and led by experts from SNMMI's specialty councils and centers of excellence. These sessions are designed to expand your knowledge on the latest clinical applications and best practices in the field advancing precision medicine. Topics in this track include: Prostate Cancer Theranostics; The Changing Landscape of Nuclear Myocardial Perfusion Imaging in 2020; Nuts & Bolts of Modern SPECT MPI;  and the Development Pipeline of a New Radiopharmaceutical Drug: From Concept to CMS Reimbursement.

Thursday, January 23

Molecular Imaging of Infection (Part I): Current Status, Future Directions, and Barriers to Advancement
This session will provide attendees with an overview of the current state of molecular imaging of infection, an update on emerging molecular imaging agents, such as 18F-flurodeoxysorbitol and 11C-trimethoprim for detecting and monitoring infection, and a review of the barriers to the development of these agents that need to overcome.

Presentations include:

  • Current Status
  • Bacteria Specific Agents
  • Radiolabeled Antibiotics
  • Barriers to Advancement – Panel Discussion

 

Molecular Imaging of Infection (Part II): Spotlight on Spondylodiscitis
This joint session will review the clinical aspects of spondylodisicitis, the radiologic diagnosis of this entity, and the role of different molecular imaging tracers for diagnosis and monitoring treatment response. Advantages and disadvantages of each of the imaging modalities, as well as diagnostic criteria will be reviewed. Updates on the increasing role of 18F-FDG PET/CT, PET/MR and SPECT/CT will be emphasized.

Presentations include:

  • Clinical and Radiological Aspects of Spondylodiscitis
  • Single Photon Emitting Agents in Spondylodiscitis
  • FDG PET/CT for Imaging of Spondylodiscitis

 

Response Assessment in the Setting of PRRT
Session information coming soon.

Friday, January 24 

Technological Developments and Fundamentals of Quantitative PET
This session will focus on the foundations of PET and will highlight the key advances and applications in PET imaging. The session will also provide functional and practical understanding of the image reconstruction process, its limitations, and provide an understanding of data modeling in both contexts of clinical and research.  You will leave this session with a deeper understanding in quantitative PET, with an eye to improve diagnosis, prognosis and treatment response assessment, and to take a significant step towards realization of precision, personalized medicine.

Presentations include:

  • Technology Review, Development in PET/CT, PET/MR and Total Body PET
  • Basics of Image Reconstruction Review and Data Analysis
  • Quality Control, Acceptance Testing and Quantitative Imaging
  • Dynamic Imaging, Parametric Imaging, Kinetic Modeling


The Changing Landscape of Nuclear Myocardial Perfusion Imaging in 2020
This session is based on new information that is important to nuclear imaging practitioners. It covers new PET and SPECT hardware and new tracers and delivery systems. It also reviews important new potential challenges to the nuclear cardiology market, including new guidelines concerning the role of CT and CT-FFR for appropriate patients, and the results of the Ischemia Trial. It will provide practical information on measuring PET blood flow, including how to perform it, quality control it, and report it.

Presentations include:

  • Exciting New Technology: Digital PET and Hybrid Whole-Body CZT
  • Update on PET Quantification of Myocardial Blood Flow
  • New Tracers for PET MPI: Flurpiridaz, Dose on Demand Ammonia and Constant Flow

 

Evidence-Based Nuclear Medicine in Theory and Practice
In this session you will receive an introduction to EBM and how it can be applied to nuclear medicine in a general manner, and EBM processes in the JNM. In addition, representatives of the SNMMI Guidance Oversight Committee will discuss the legislative demand and Societies’ response for Appropriate Use Criteria (AUC), EBM, and SNMMI guidance documents.

Presentations include: 

  • Introduction to Evidence Based Medicine (EBM) in the Domain of Nuclear Medicine
  • EBM and the Journal of Nuclear Medicine
  • The Legislative Demand for AUC (PAMA), the CMS Requirements for AUC, and the Response of Medical Societies
  • EBM and SNMMI Guidance Documents

 

Health Services Research in Nuclear Medicine and Molecular Imaging – Measuring Our Effectiveness
In this session, you'll gain a better understanding of the role of health services research (HSR) in the fields of molecular imaging and therapy, and the implementation of new care models based on value rather than fee-for-service. In addition, the session will cover patient-centered decision-making in medicine, including understanding performance, quality, effectiveness, and efficiency of molecular imaging and molecular therapeutics.

Presentations include:

  • What is Health Services Research and How Does it Apply to Me?
  • There’s a Method to the Madness: Measuring Quality, Cost, Outcomes, and Comparative Effectiveness
  • The Power of Data and its Visualization
  • Real Life Implementation of Health Services Research

 

Saturday, January 25

Development Pipeline of a New Radiopharmaceutical Drug – From Concept to Reimbursement 
This session will explore the process of radiopharmaceutical development: from initial identification of a biological target to obtaining CMS reimbursement and widespread application. Specific stages of development will be explored in 4 different talks to identify key steps and pitfalls that investigators make in pursuing FDA approval of a radiopharmaceutical.

Presentations include:

  • Radiopharmaceutical Development: Concept through Animal Studies
  • Radiopharmaceutical Development: Animal Studies to Initial Human Imaging
  • Radiopharmaceutical Development:  Human Trials to FDA Approval
  • Radiopharmaceutical Development:  FDA Approval through CMS Reimbursement

 

Cardiovascular Inflammation/Infection Case-Based Workshop
This is a heavily case-based review on cardiovascular inflammation/infection addressing specifically sarcoid, amyloid, and vascular topics.  This will provide the participants on information on how to protocol these patients and how to interpret the images. The latest recommendations from literature will also be included.

Presentations include:

  • Cardiac Sarcoid
  • Cardiac Amyloid
  • Vascular and Device/Valve Infections
  • Case-Based Review

 

Nuts and Bolts of Modern SPECT Myocardial Perfusion Imaging 
This session is meant to be focused on the basics of SPECT myocardial perfusion imaging, from a 2020 context. As such, it will emphasize image interpretation, focusing on how to integrate visual and quantitative parameters.  A second presentation will cover the topic of quantifying myocardial blood flow with both CZT and Anger SPECT. A third presentation will be on practical tips on dealing with current drug shortages and laboratory emergencies, such as handling high grade heart block, asystole, severe bronchospasm, and seizures in relation to pharmacologic stressors. The final presentation will be case-based image interpretations of challenging SPECT and PET cases.

Presentations include:

  • Practical Guide to Integrating Quantification into Scan Interpretation
  • Quantifying Blood Flow with Anger & CZT SPECT Systems
  • Handling Current Medication Shortages and Lab Emergencies
  • Challenging SPECT and PET Cases

 

Prostate Cancer Theranostics
This session is intended to teach physicians and technologists about prostate cancer and theranostics including PSMA PET/CT and PSMA therapy.

Presentations include:

  • Clinical Aspects of Prostate Cancer Management
  • Prostate Cancer Theranostics
  • Prostate Cancer Theranostics from a Technologist's Perspective
  • Patient Perspective on Prostate Theranostics